Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbenoxolone in impaired glucose tolerance
2006-003426-28Phase 2Terminated
- Sponsor
- University Hospitals Birmingham
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carbenoxolone in prediabetes (2 arms), sponsored by University Hospitals Birmingham. Primary endpoints: Glycemic control after treatment, Insulin secretion and 2 more. Started Jun 2007; status: terminated.
02
Drugs
carbenoxolone
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2006-003426-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003426-28.